While both peptides are studied for appetite regulation and glucose metabolism, the Tirzepatide peptide acts as a dual GLP-1 and GIP receptor agonist, whereas Retatrutide is a triple agonist that also targets the glucagon receptor
Overall, more time is needed to determine whether or not GLP-1 drugs can be used to control autoimmunity and inflammation in those with or without obesity and how best to utilize the medications for these purposes
When combined with semaglutide, this interaction can delay your metabolic adaptation phase, the first 46 weeks when your body adjusts to GLP-1 signaling
Lees ook: Wanneer heb je overgewicht/obesitas
These specialists can provide comprehensive evaluation and determine if further investigation is warranted
En un estudio separado, la terapia baritrica endoscpica ms liraglutida produjo una prdida de peso total del 25%